Journal of Medical - Clinical Research & Reviews

Open Access ISSN: 2639-944X

Abstract


Atrial Fibrillation is Not A Dead Horse

Authors: Fiori P, Allegorico L, Capaldo G, Massarelli M, Gizzi R, Pelosi C, Savino P, Bellizzi A, Bianchino G, Botticella F, Di Gianni A, Dragonetti C, Gualdiero P, Lo Conte C, Manganelli G, Minichiello S, Morella A, Pellecchia V, Bellizzi G, Alberico M, Benigni G, Damiano T, De Caro M, Pace E, Ferrara M, Martino A, Mazza E, Esposito G, Tammaro C, et al.

Prevalence and incidence of Atrial Fibrillation (AF) is high in western countries. It is apparently lower in developing countries, because of unrecognition, undertreatment and related complications and mortality. Studies in subjects wearing cardiac implantable electronic devices showed a wide burden of AF, ranging from subclinical episodes to permanent AF.

The aim of our study was to identify haematological and haemodynamic differences between Paroxysmal Atrial Tachyarrhythmias (PAT) compared to Non-Paroxysmal AF (NPAF), detected by 24 hours Holter ECG, and predictive negative factors associated with increased risk of evolution from paroxysmal to persistent or permanent AF.

Our data highlight the dynamic nature of PAT and NPAF. PAT in young subjects is a red flag, requiring at least changes in lifestyle and further diagnostic examinations to avoid progression to irreversible pathological myocardial electrical and structural remodeling. Comorbidities, scarce compliance, or inappropriate treatments account for high incidence of acute cerebrovascular events with disabling outcomes in elderly patients. Further studies are needed on genetic susceptibility and vulnerability. Educational campaign is the most effective, long- term strategy. Personalized approach and therapeutical scheme are recommended based on patient compliance and actual risk. A holistic approach to patient is the pillar for any clinical decision and practice.

View/Download pdf